Personalized medication plan 100% online visit and checkout Shipped straight to your door Free GLP-1 shot tracking app *In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)
It is a synthetic analog of gastric inhibitory polypeptide (GIP) that also exhibits glucagon-like peptide-1 (GLP-1) receptor agonist activity
However, the absence of large-scale human trials, FDA approval, and standardized sourcing means that patients should proceed with caution
Always follow your health care providers instructions to ensure safe and effective management of your health conditions
This happens with any rapid weight loss method, not just Wegovy
While those results are possible, they often represent patients who: Patients should avoid comparing their progress directly to photos found online